Anti-CGRP monoclonal antibodies for the treatment of chronic migraine: an overview of available results and comparison with the currently used prophylactics

被引：0
|
作者：
Vandervorst, Fenne [1 ]
Van Deun, Laura [1 ]
De Keyser, Jacques [1 ]
Versijpt, Jan [1 ]
机构：
[1] Univ Hosp Brussels, Dept Neurol, Brussels, Belgium
来源：
JOURNAL OF HEADACHE AND PAIN | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ANTI-CGRP MONOCLONAL ANTIBODIES FOR THE TREATMENT OF EPISODIC MIGRAINE: AN OVERVIEW OF AVAILABLE RESULTS AND COMPARISON WITH THE CURRENTLY USED PROPHYLACTICS
    Vandervorst, F.
    Van Deun, Laura
    De Keyser, Jacques
    Paemeleire, Koen
    Versijpt, Jan
    [J]. CEPHALALGIA, 2018, 38 : 151 - 151
  • [2] Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
    Hugo Sevivas
    Paula Fresco
    [J]. European Journal of Medical Research, 27
  • [3] Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
    Sevivas, Hugo
    Fresco, Paula
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [4] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Fred Cohen
    Hsiangkuo Yuan
    E. M. G. DePoy
    Stephen D. Silberstein
    [J]. Neurotherapeutics, 2022, 19 : 922 - 930
  • [5] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine
    Hennessy, Elise
    Salim, Amira
    Biswas, Sudipa
    Suneja, Aarushi
    Mays, Maryann
    Ahmed, Zubair
    Mata, Ignacio
    [J]. NEUROLOGY, 2023, 100 (17)
  • [6] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Cohen, Fred
    Yuan, Hsiangkuo
    DePoy, E. M. G.
    Silberstein, Stephen D.
    [J]. NEUROTHERAPEUTICS, 2022, 19 (03) : 922 - 930
  • [7] Synergism of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in the treatment of migraine
    Hennessy, E.
    Salim, A.
    Biswas, S.
    Sonneborn, C.
    Hogue, O.
    Suneja, A.
    Mays, M.
    Ahmed, Z.
    Mata, I
    [J]. HEADACHE, 2023, 63 : 170 - 171
  • [8] Anti-CGRP monoclonal antibodies in migraine: current perspectives
    Giamberardino, Maria Adele
    Affaitati, Giannapia
    Curto, Martina
    Negro, Andrea
    Costantini, Raffaele
    Martelletti, Paolo
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (08) : 1045 - 1057
  • [9] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
    van der Arend, Britt W. H.
    van Veelen, Nancy
    de Ruijter, Joelle E. T.
    Olsen, Michael H.
    van den Brink, Antoinette Maassen
    Terwindt, Gisela M.
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
  • [10] Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment
    Salim, Amira
    Najjar, Atia
    Ahmed, Zubair
    Mata, Ignacio
    [J]. NEUROLOGY, 2023, 100 (17)
12345